Editorial.
作者信息
Macià Miquel, Llacer-Moscardo Carmen
出版信息
Rep Pract Oncol Radiother. 2017 Mar-Apr;22(2):83-85. doi: 10.1016/j.rpor.2016.09.011. Epub 2016 Oct 15.
Abstract
摘要
相似文献
1
Editorial.
Rep Pract Oncol Radiother. 2017 Mar-Apr;22(2):83-85. doi: 10.1016/j.rpor.2016.09.011. Epub 2016 Oct 15.
2
[How to draft editorial explanation for transparent and concise guideline on clinical practice--Case analysis].
Zhongguo Zhong Yao Za Zhi. 2017 Dec;42(23):4520-4528. doi: 10.19540/j.cnki.cjcmm.20171012.007.
3
Editorial behaviors in peer review.
Springerplus. 2016 Jun 27;5(1):903. doi: 10.1186/s40064-016-2601-y. eCollection 2016.
4
Composition of the editorial boards of leading medical education journals.
BMC Med Res Methodol. 2004 Jan 20;4:3. doi: 10.1186/1471-2288-4-3.
5
Editorial bias in scientific publications.
Neurologia. 2011 Jan-Feb;26(1):1-5. doi: 10.1016/j.nrl.2010.11.001. Epub 2011 Jan 8.
6
Gender and Editorial Authorship in High-Impact Epidemiology Journals.
Am J Epidemiol. 2019 Dec 31;188(12):2140-2145. doi: 10.1093/aje/kwz094.
7
How international are the leading orthopedic journals: a look at the composition of the editorial board members of the top orthopedic journals.
Arch Orthop Trauma Surg. 2014 May;134(5):619-22. doi: 10.1007/s00402-014-1975-y. Epub 2014 Mar 18.
8
Publication rates of editorial board members in oral health journals.
Braz Oral Res. 2014;28. doi: 10.1590/1807-3107bor-2014.vol28.0042. Epub 2014 Aug 26.
9
Meeting report of the editorial board meeting for 2019.
World J Hepatol. 2020 Jan 27;12(1):1-5. doi: 10.4254/wjh.v12.i1.1.
10
The prevalence and influence of self-reported conflicts of interest by editorial authors of phase III cancer trials.
Contemp Clin Trials. 2012 Sep;33(5):1019-22. doi: 10.1016/j.cct.2012.05.011. Epub 2012 Jun 1.
本文引用的文献
1
Other non-surgical treatments for liver cancer.
Rep Pract Oncol Radiother. 2017 Mar-Apr;22(2):181-192. doi: 10.1016/j.rpor.2017.02.007. Epub 2017 Apr 14.
2
Management of liver cancer. The Surgeon's point of view.
Rep Pract Oncol Radiother. 2017 Mar-Apr;22(2):176-180. doi: 10.1016/j.rpor.2017.02.001. Epub 2017 Mar 23.
3
Evaluation of response after SBRT for liver tumors.
Rep Pract Oncol Radiother. 2017 Mar-Apr;22(2):170-175. doi: 10.1016/j.rpor.2015.12.004. Epub 2015 Dec 30.
4
The role of SBRT in oligometastatic patients with liver metastases from breast cancer.
Rep Pract Oncol Radiother. 2017 Mar-Apr;22(2):163-169. doi: 10.1016/j.rpor.2016.07.008. Epub 2016 Sep 5.
5
Stereotactic body radiation therapy for liver metastasis - The linac-based Greater Poland Cancer Centre practice.
Rep Pract Oncol Radiother. 2017 Mar-Apr;22(2):158-162. doi: 10.1016/j.rpor.2017.02.008. Epub 2017 Apr 4.
6
Image guided SBRT for multiple liver metastases with ExacTrac Adaptive Gating.
Rep Pract Oncol Radiother. 2017 Mar-Apr;22(2):150-157. doi: 10.1016/j.rpor.2016.07.006. Epub 2016 Sep 17.
7
Imaged-guided liver stereotactic body radiotherapy using VMAT and real-time adaptive tumor gating. Concerns about technique and preliminary clinical results.
Rep Pract Oncol Radiother. 2017 Mar-Apr;22(2):141-149. doi: 10.1016/j.rpor.2016.06.004. Epub 2016 Sep 5.
8
Evaluation of reproducibility of tumor repositioning during multiple breathing cycles for liver stereotactic body radiotherapy treatment.
Rep Pract Oncol Radiother. 2017 Mar-Apr;22(2):132-140. doi: 10.1016/j.rpor.2016.07.007. Epub 2016 Nov 12.
9
Institutional experience in the treatment of colorectal liver metastases with stereotactic body radiation therapy.
Rep Pract Oncol Radiother. 2017 Mar-Apr;22(2):126-131. doi: 10.1016/j.rpor.2016.10.003. Epub 2016 Dec 2.
10
Radiosurgery for liver metastases. A single institution experience.
Rep Pract Oncol Radiother. 2017 Mar-Apr;22(2):118-125. doi: 10.1016/j.rpor.2016.10.001. Epub 2016 Dec 21.
Zotero 插件